Cannabis Bioscience International Holdings, Inc. Overview
Industry: Drug Manufacturers-Specialty & Generic
Sector: Healthcare
China Infrastructure Construction Corp. provides educational systems that focuses on medical cannabis in the United States and Latin America, and worldwide through online education. The company offers services in the therapeutic areas of clinical trials; and relating to sleep disorders, including resulting infertility, through its fertility and sleep center in Houston, Texas. It also offers education, consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. The company was founded in 2003 and is headquartered in Houston, Texas.
Cannabis Bioscience International Holdings, Inc. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Cannabis Bioscience International Holdings, Inc. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Cannabis Bioscience International Holdings, Inc. Competitors
Cannabis Bioscience International Holdings, Inc. operates in the Drug Manufacturers-Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans